BI-1265162, an inhaled ENaC inhibitor for the mutation-agnostic treatment of cystic fibrosis Sep. 6, 2021 No Comments
HEC-866, a novel pirfenidone analogue with improved therapeutic efficacy in models of IPF Sep. 6, 2021 No Comments
RSS